COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
NICE CKS—constipation in adults
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title, it therefore only covers the information relevant to this setting, and is deliberately concise. Areas covered in the summary include: advice for those with the condition, management (short-duration and chronic), secondary causes of the condition, and prescribing information. Please refer to the full NICE guideline for the complete set of recommendations and references.
Dealing with chronic constipation—information for GPs
This summary highlights the results of research on constipation and treatment options and combines them into a simple diagram to help guide and provide a best practice pathway for general practice in its recognition, treatment, and point of escalation for the available therapies for chronic constipation. For further information, please view the full guidance together with the NICE Clinical Knowledge Summary on constipation.
NICE CKS—diarrhoea
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. For community pharmacists, the referral section implies primary care referral prior to secondary care referral. Please see the full guideline for the complete set ...
NICE coeliac disease guideline
This useful summary covers the recognition, referral and monitoring of people with coeliac disease.
Promotional content
ClinOwl - A new resource for healthcare professionals
A free resource, which aggregates and curates the latest clinical articles from leading medical journals in a single view. Keep up to date quickly and easily. You will be redirected to ClinOwl.com.
Educational resources
NICE Technology Appraisal 651: Naldemedine ▼ for treating opioid‑induced constipation
The production and printing of this Guidelines summary card has been commissioned by Sandoz Ltd. Information intended for UK healthcare professionals only.
View prescribing information
UK/P/RZM/20-0016c October 2020
The role of peripherally acting µ-opioid receptor antagonists (PAMORAs) in the management of opioid-induced constipation (OIC)
This educational reference document has been initiated, commissioned, and developed by Sandoz Ltd. Information intended for UK healthcare professionals only.
View prescribing information
UK/MKT/RZM/20-0029f October 2020
Diagnosis and initial treatment of opioid-induced constipation
This webinar has been initiated and commissioned by Sandoz Ltd and organised in partnership with Guidelines.
View prescribing information
UK/MKT/RZM/20-0032f
Pancreatic exocrine insufficiency guideline
This management algorithm was developed by a multidisciplinary expert panel: Hambling C et al with the support of a grant from Mylan Ltd.